MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

In order to prevent the diseases that killed many refugees in Yida camp, South Sudan, in 2012, Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a water and sanitation program and begun a vaccination campaign for children. The campaign was pushed back to start now, during the logistically difficult rainy season, because MSF had to engage in lengthy negotiations to get the vaccine at an affordable price.

More >

MSF's Kate Elder explains how the high price of vaccines prevents many children from being immunized.

More >

Research presented by Epicentre, MSF's epidemiological research arm, and other African researchers adds to evidence that the two existing rotavirus vaccines may not be best adapted for use in Africa.

More >

The US and European Union delegations to the World Health Assembly are blocking efforts to move towards a binding convention on health R&D aimed at filling critical medical gaps for people in developing countries.

More >

A new, ten-year, multi-billion dollar action plan for global vaccination may fail to deliver if it does not directly address the weaknesses in routine immunization programs. 

More >

MSF has released a list of important stories that had an impact on people’s ability to access needed drugs, diagnostics, and vaccines in developing countries in 2011.

More >

New York, New York, December 1, 2008—A partial dose of a commonly used vaccine against meningitis may be as effective as a full dose, according to newly published research in PLoS Neglected Tropical Diseases. Fractional dosing would enable large-scale vaccination campaigns during epidemics, especially at a time of global vaccine shortages.

More >

Geneva, September 25th 2003 - The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warns that thousands of lives could be lost in Africa if donors fail to fund the production of a new meningitis vaccine in the next two weeks. Prompt action is needed to ensure supplies will be available when the next meningitis epidemic season begins in Africa in late 2003 or early 2004. So far, MSF is the only organization to allocate funds (€ 1 million) to purchase the vaccine.

More >

Geneva, February 6, 2003 - Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the new trivalent (ACW135) meningitis vaccine developed by GlaxoSmithKline. MSF is particularly encouraged to see that the new product was registered so quickly, in only a few months, while last August, companies and regulatory authorities still argued such a quick maneuver wouldn't be feasible.

More >